Target intelligence / Profile preview

RNA, U6 small nuclear 728, pseudogene (RNU6-728P)

Target
RNU6-728P
Molecular classification
Other (non-coding RNA pseudogene), snRNA pseudogene
01

Overview

RNA, U6 small nuclear 728, pseudogene (RNU6-728P) is classified as a **pseudogene** of the U6 small nuclear RNA gene family[1]. Pseudogenes such as RNU6-728P are **non-coding sequences** that resemble functioning genes but are generally considered non-functional due to mutations or lack of regulatory elements[2]. U6 snRNA genes encode components of the spliceosome, a complex essential for excising introns from pre-mRNA during RNA splicing[3][7]. The pseudogene RNU6-728P is a genomic relic generated by retrotransposition events, notably mediated by LINE-1 elements, leading to the integration of non-functional snRNA copies throughout mammalian genomes[2][5]. Unlike canonical U6 snRNA, which is crucial for splicing, pseudogenes such as RNU6-728P **do not produce functional RNA** or have a known biological or disease function, and are not considered active therapeutic, diagnostic, or receptor targets[1][2][4]. Key points: - RNU6-728P is a non-coding **snRNA pseudogene**[1]. - It does **not encode a receptor, enzyme, transporter, or druggable target**[1][2][4]. - No evidence links RNU6-728P to disease mechanisms, drug response, or clinical biomarkers[1][2][4]. - Its only notable role is as a genomic marker of retrotransposition history within the genome[2][5]. This molecule should be classified as a **pseudogene (non-coding RNA, not a therapeutic or biological target)**.

Other names
RNU6-728PU6 small nuclear RNA pseudogene 728

Beyond the preview

Go deeper on RNA, U6 small nuclear 728, pseudogene (RNU6-728P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 728, pseudogene (RNU6-728P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call